The Mystery Behind India’s Success in Flattening the Curve
Considering the burden on hospitals, the decision was made to treat the asymptomatic and mild cases at home and moderate and severe cases in the hospitals.
Tag: india
Avez-vous entendu parler de la thérapie ZIVERDO pour le COVID-19?
Ceci est un bref essai, une chaîne de pensées, d’une thérapie à 2 $ … à la chute des nations… (rien de moins! ) Article available
Did you Hear about the ZIVERDO Therapy for COVID-19?
This is a brief essay, a chain of thoughts, from a $2 therapy to … the fall of nations … (nothing less!) Article available in
HCQ in COVID-19 under Trial: With RCTs in Witness Box
Guest article by Dr Dhananjay Bakhle, Executive Vice President – Medical Research, Lupin. One of the most important aspects of a clinical trial publication is
Healthcare Workers Protected by HCQ Prophylaxis – Study
The study “Pre-exposure Hydroxychloroquine use is associated with reduced COVID19 risk in healthcare workers, by Bhattacharya and collaborators, found efficacy in pre-exposure prophylaxis for medical
New Prophylaxis Guidelines Issued in India Rely on Hydroxychloroquine
According to a May 22nd media release, the Joint Monitoring Group under the Chairmanship of DGHS and including representatives from AIIMS, ICMR, NCDC, NDMA, WHO
